MDT

86.26

-0.28%↓

A

114.89

-0.48%↓

VEEV

174.73

+0.5%↑

HQY

83.39

-1.43%↓

PHR.US

9.05

+8.51%↑

MDT

86.26

-0.28%↓

A

114.89

-0.48%↓

VEEV

174.73

+0.5%↑

HQY

83.39

-1.43%↓

PHR.US

9.05

+8.51%↑

MDT

86.26

-0.28%↓

A

114.89

-0.48%↓

VEEV

174.73

+0.5%↑

HQY

83.39

-1.43%↓

PHR.US

9.05

+8.51%↑

MDT

86.26

-0.28%↓

A

114.89

-0.48%↓

VEEV

174.73

+0.5%↑

HQY

83.39

-1.43%↓

PHR.US

9.05

+8.51%↑

MDT

86.26

-0.28%↓

A

114.89

-0.48%↓

VEEV

174.73

+0.5%↑

HQY

83.39

-1.43%↓

PHR.US

9.05

+8.51%↑

Search

Progyny Inc

Chiusa

SettoreSettore sanitario

16.76 0.96

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

16.19

Massimo

16.89

Metriche Chiave

By Trading Economics

Entrata

-1.4M

12M

Vendite

5.1M

318M

P/E

Media del settore

26.108

56.063

Margine di Profitto

3.921

Dipendenti

835

EBITDA

-6M

19M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+63.98% upside

Dividendi

By Dow Jones

Utili prossimi

7 mag 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-447M

1.4B

Apertura precedente

15.8

Chiusura precedente

16.76

Notizie sul Sentiment di mercato

By Acuity

29%

71%

100 / 349 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bullish Evidence

Progyny Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

6 apr 2026, 23:17 UTC

Utili

Samsung Forecasts Record First-Quarter Operating Profit

6 apr 2026, 23:00 UTC

Azioni calde

Stocks to Watch: Health Insurers, Mawson, Owlet

6 apr 2026, 22:13 UTC

I principali Market Mover

Health Insurance Shares Gain on 2.48% Medicare Rate Bump

6 apr 2026, 21:46 UTC

Acquisizioni, Fusioni, Takeovers

BP 'Optimizes Portfolio' and Sells 13 Thorntons Stores to Giant Oil -- OPIS

6 apr 2026, 17:09 UTC

I principali Market Mover

Viridian Shares Fall After Competing Amgen Eye Drug Performs Well

6 apr 2026, 16:56 UTC

Principali Notizie su Eventi

U.S. Released 1.5 Million Bbls of Crude From SPR Last Week, DOE Data Show -- OPIS

6 apr 2026, 14:47 UTC

I principali Market Mover

Stereotaxis Shares Rise on FDA Clearance for Synchrony

7 apr 2026, 00:00 UTC

Principali Notizie su Eventi

Ukraine's Lesson for Trump: Military Dominance Opens Waterways -- WSJ

6 apr 2026, 23:58 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Iran War Will Keep Oil Prices High Through 2Q, Says Westpac -- Market Talk

6 apr 2026, 23:50 UTC

Discorsi di Mercato

Nikkei May Rise on Hopes for Iran Cease-Fire -- Market Talk

6 apr 2026, 23:36 UTC

Discorsi di Mercato

Gold Edges Higher as Investors Focus on U.S.-Iran Conflict -- Market Talk

6 apr 2026, 23:15 UTC

Discorsi di Mercato

RBA Won't Raise Rates as Australia's Economy Softens Fast -- Market Talk

6 apr 2026, 22:52 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

6 apr 2026, 22:52 UTC

Discorsi di Mercato

Pro Medicus Unlikely to Complete New Buyback in Full -- Market Talk

6 apr 2026, 22:14 UTC

Discorsi di Mercato

Correction to Live Cattle Futures Article

6 apr 2026, 20:56 UTC

Discorsi di Mercato

Mexican Private Consumption Fell in January -- Market Talk

6 apr 2026, 20:50 UTC

Discorsi di Mercato

Energy & Utilities Roundup: Market Talk

6 apr 2026, 20:15 UTC

Discorsi di Mercato

Global Commodities Roundup: Market Talk

6 apr 2026, 19:58 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

6 apr 2026, 19:58 UTC

Discorsi di Mercato

Live Cattle Futures Hit Record High, Hogs Edge Up -- Market Talk

6 apr 2026, 19:11 UTC

Discorsi di Mercato

U.S. Natural Gas Edges Up in Rangebound Trade -- Market Talk

6 apr 2026, 19:06 UTC

Discorsi di Mercato

Treasury Yields Decline as a Belligerent Trump Talks to Reporters -- Market Talk

6 apr 2026, 19:03 UTC

Discorsi di Mercato

Global Energy Roundup: Market Talk

6 apr 2026, 19:03 UTC

Discorsi di Mercato

Crude Futures Edge Up As Trump's Iran Deadline Nears -- Market Talk

6 apr 2026, 18:36 UTC

Acquisizioni, Fusioni, Takeovers

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 apr 2026, 17:59 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Travel Booking Companies Facing More Demand Uncertainty Than Expected -- Market Talk

6 apr 2026, 17:13 UTC

Acquisizioni, Fusioni, Takeovers

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 apr 2026, 16:33 UTC

Discorsi di Mercato

Oil Futures Steady as Market Awaits Trump -- Market Talk

6 apr 2026, 16:20 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

6 apr 2026, 14:59 UTC

Utili

Strategy Records a $14.5 Billion Unrealized Loss in First Quarter -- WSJ

Confronto tra pari

Modifica del prezzo

Progyny Inc Previsione

Obiettivo di Prezzo

By TipRanks

63.98% in crescita

Previsioni per 12 mesi

Media 27.22 USD  63.98%

Alto 31 USD

Basso 19 USD

Basato su 9 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Progyny Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

9 ratings

7

Acquista

2

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

22.91 / 23.375Supporto e resistenza

A breve termine

Strong Bullish Evidence

A termine intermedio

Bullish Evidence

A lungo termine

Bullish Evidence

Sentiment

By Acuity

100 / 349 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Progyny Inc

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
help-icon Live chat